Post-marketing studies of pharmaceutical opioid abuse-deterrent formulations: a framework for research design and reporting-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Post-marketing studies of pharmaceutical opioid abuse-deterrent formulations: a framework for research design and reporting

Published:2018-09-07 Issue:3 Volume:114 Page:389-399
ISSN:0965-2140
Container-title:Addiction
language:en
Short-container-title:Addiction

Author:

Peacock Amy¹²^ORCID,Larance Briony¹,Bruno Raimondo¹²,Pearson Sallie-Anne³,Buckley Nicholas A.⁴,Farrell Michael¹^ORCID,Degenhardt Louisa¹^ORCID

Affiliation:

1. National Drug and Alcohol Research Centre; University of New South Wales, Australia; Sydney NSW Australia

2. School of Medicine; University of Tasmania; TAS Australia

3. Centre for Big Data Research in Health; University of New South Wales; Australia

4. Faculty of Pharmacy; University of Sydney; Australia

Publisher

Wiley

Subject

Psychiatry and Mental health,Medicine (miscellaneous)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/add.14380/fullpdf

Reference64 articles.

1. Definitions related to the use of pharmaceutical opioids: Extramedical use, diversion, non-adherence and aberrant medication-related behaviours;Larance;Drug Alcohol Rev,2011

2. The epidemiologic association between opioid prescribing, non-medical use, and emergency department visits;Wisniewski;J Addict Dis,2008

3. High correlations between levels of consumption and mortality related to strong prescription opioid analgesics in British Columbia and Ontario, 2005-2009;Fischer;Pharmacoepidemiol Drug Saf,2013

4. Institute for Clinical and Economic Review (ICER) Abuse-deterrent formulations of opioids: effectiveness and value 2017

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transparency in the secondary use of health data: Assessing the status quo of guidance and best practices;2024-08-11

2. Matching study design to prescribing intention: The prevalent new‐user design for studying abuse‐deterrent formulations of opioids;Pharmacoepidemiology and Drug Safety;2024-05

3. Pharmacovigilance Signals of the Opioid Epidemic over 10 Years: Data Mining Methods in the Analysis of Pharmacovigilance Datasets Collecting Adverse Drug Reactions (ADRs) Reported to EudraVigilance (EV) and the FDA Adverse Event Reporting System (FAERS);Pharmaceuticals;2022-05-27

4. Abuse-Deterrent Formulations in Constraining the Abuse Potential of Prescription Medicines: A Myth or Truth;Current Drug Delivery;2022-04

5. Abuse deterrent immediate release film technology (ADRIFT): A novel bilayer film technology for limiting intentional drug abuse;International Journal of Pharmaceutics;2020-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3